# Eversight Illinois – FDA Inspection, Apr 18, 2018

Source: https://www.keypedia.com/records/fda_inspections/eversight-illinois/581c8d56-785a-472c-89cd-9c2899524865
Source feed: FDA_Inspections

> FDA inspection 1055320 of Eversight Illinois, April 18, 2018. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1055320
- Company Name: Eversight Illinois
- Inspection Date: 2018-04-18
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1241628 - 2024-06-18](https://www.keypedia.com/records/fda_inspections/eversight-illinois/bcb4d369-162e-4484-8bcd-d4a62c2666d9)
- FDA Inspection 968460 - 2016-05-09
- FDA Inspection 883885 - 2014-06-18
- FDA Inspection 759437 - 2011-12-19
- FDA Inspection 634088 - 2009-12-03

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kip-j-hanks/839cb755-ff60-448c-9b21-b84b78b59a15)
- Issuing Officer
- [Issuing Officer](https://www.keypedia.com/people/uruaku-a-obasi/8ff0e6f4-da89-4ec0-86f4-7ebf8cf529b8)

Company: https://www.keypedia.com/companies/eversight-illinois/7b7a3e81-0ca7-4d57-b230-5dc8e929c6a6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
